Overview

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
It is the purpose of this study to determine the concentration of 3 allergens (goldnatriumthiosulphate, methyldibromoglutharonitrile [MDBGN], parthenolide) for diagnosing allergic contact dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Mekos Laboratories AS
Treatments:
Parthenolide